These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 1464286)

  • 1. In vivo X-ray fluorescence of lead in bone.
    Todd AC; McNeill FE; Fowler BA
    Environ Res; 1992 Dec; 59(2):326-35. PubMed ID: 1464286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo X-ray fluorescence of lead in bone: review and current issues.
    Todd AC; Chettle DR
    Environ Health Perspect; 1994 Feb; 102(2):172-7. PubMed ID: 8033846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lead in bone: sampling and quantitation using K X-rays excited by 109Cd.
    Chettle DR; Scott MC; Somervaille LJ
    Environ Health Perspect; 1991 Feb; 91():49-55. PubMed ID: 2040251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo X-ray fluorescence of lead in bone using K X-ray excitation with 109Cd sources: radiation dosimetry studies.
    Todd AC; McNeill FE; Palethorpe JE; Peach DE; Chettle DR; Tobin MJ; Strosko SJ; Rosen JC
    Environ Res; 1992 Apr; 57(2):117-32. PubMed ID: 1568436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary studies on combining the K and L XRF methods for in vivo bone lead measurement.
    Lee SH; Gardner RP; Todd AC
    Appl Radiat Isot; 2001 Jun; 54(6):893-904. PubMed ID: 11300402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvements in the calibration of 109Cd K x-ray fluorescence systems for measuring bone lead in vivo.
    Aro AC; Todd AC; Amarasiriwardena C; Hu H
    Phys Med Biol; 1994 Dec; 39(12):2263-71. PubMed ID: 15551552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors affecting in vivo measurement precision and accuracy of 109Cd K x-ray fluorescence measurements.
    McNeill FE; Stokes L; Chettle DR; Kaye WE
    Phys Med Biol; 1999 Sep; 44(9):2263-73. PubMed ID: 10495120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Workshop on the X-ray fluorescence of lead in bone: conclusions, recommendations and summary.
    Todd AC; Landrigan PJ; Bloch P
    Neurotoxicology; 1993; 14(1):145-54. PubMed ID: 8361673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normalisation with coherent scatter signal: improvements in the calibration procedure of the 57Co-based in vivo XRF bone-Pb measurement.
    O'Meara JM; Börjesson J; Chettle DR; Mattsson S
    Appl Radiat Isot; 2001 Feb; 54(2):319-25. PubMed ID: 11200895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. X-ray fluorescence: issues surrounding the application of a new tool for measuring burden of lead.
    Hu H; Milder FL; Burger DE
    Environ Res; 1989 Aug; 49(2):295-317. PubMed ID: 2753011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monte Carlo simulation of source-excited in vivo x-ray fluorescence measurements of heavy metals.
    O'Meara JM; Chettle DR; McNeill FE; Prestwich WV; Svensson CE
    Phys Med Biol; 1998 Jun; 43(6):1413-28. PubMed ID: 9651014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Non-invasive determination of bone lead in human body using X-ray fluorescence excited by 109Cd].
    Huang SB; Tian L; Cheng HS; Pei P
    Guang Pu Xue Yu Guang Pu Fen Xi; 2004 Nov; 24(11):1470-2. PubMed ID: 15762508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An investigation of the 109Cd gamma-ray induced K-x-ray fluorescence (XRF) bone-lead measurement calibration procedure.
    Nie H; Chettle DR; McNeill FE; O'Meara JM
    Phys Med Biol; 2004 Oct; 49(19):N325-34. PubMed ID: 15552425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new anthropometric phantom for calibrating in vivo measurements of stable lead in the human leg using x-ray fluorescence.
    Spitz H; Jenkins M; Lodwick J; Bornschein R
    Health Phys; 2000 Feb; 78(2):159-69. PubMed ID: 10647982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of K X-ray fluorescence for measuring lead burden in epidemiological studies: high and low lead burdens and measurement uncertainty.
    Hu H; Milder FL; Burger DE
    Environ Health Perspect; 1991 Aug; 94():107-10. PubMed ID: 1954919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An agreed statement on calculating lead concentration and uncertainty in XRF in vivo bone lead analysis.
    Chettle DR; Arnold ML; Aro AC; Fleming DE; Kondrashov VS; McNeill FE; Moshier EL; Nie H; Rothenberg SJ; Stronach IM; Todd AC
    Appl Radiat Isot; 2003 May; 58(5):603-5. PubMed ID: 12735978
    [No Abstract]   [Full Text] [Related]  

  • 17. Corrections to "How to calculate lead concentration and concentration uncertainty in XRF in vivo bone lead analysis" by Kondrashov and Rothenberg.
    Todd AC; Moshier EL; Arnold M; Aro A; Chettle DR; McNeill FE; Nie H; Flemming DE; Stronach IM
    Appl Radiat Isot; 2003 Jan; 58(1):41-50; author reply 51-4. PubMed ID: 12485662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vivo determination of Pb in human bone by using X-ray fluorescence analysis].
    Luo LQ; Xu T; Chu BB; Sun JL; Egden L; Chettle L; Wang XF; Bo Y; Liu Y; Wang SX; Tang LJ; Li YC
    Guang Pu Xue Yu Guang Pu Fen Xi; 2012 Mar; 32(3):821-5. PubMed ID: 22582661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo quantification of lead in bone with a portable x-ray fluorescence system--methodology and feasibility.
    Nie LH; Sanchez S; Newton K; Grodzins L; Cleveland RO; Weisskopf MG
    Phys Med Biol; 2011 Feb; 56(3):N39-51. PubMed ID: 21242629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of the specific purpose Monte Carlo code CEARXRF for the design and use of in vivo X-ray fluorescence analysis systems for lead in bone.
    Ao Q; Lee SH; Gardner RP
    Appl Radiat Isot; 1997; 48(10-12):1403-12. PubMed ID: 9463866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.